On January 15, 2025, the U.S. Department of Justice announced that it obtained more than $2.9 billion from 558 different False Claims Act settlements and judgments in fiscal year 2024. According to DOJ, these 558 settlements and judgments were the “second highest total after last year’s record of 566 recoveries,” and “over $1.67 billion” of DOJ’s recoveries “related to matters that involved the health care industry.”
DOJ’s press release emphasized that “health care fraud remained a leading source of False Claims Act settlements and judgments” and highlighted the wide range of health care matters that resulted in recoveries in fiscal year 2024. These matters included, among other things, suits against pharmacies and providers related to the opioid epidemic, suits against pharmaceutical manufacturers for alleged kickbacks and inflated price reporting, and suits against provider organizations and labs for alleged kickbacks and “medically unnecessary services and substandard care.”